Reported Feb 2, 2022 · Terminated
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC…
Aurobindo Pharma USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aurobindo Pharma USA Inc. · 279 Princeton Hightstown Rd · East Windsor, NJ · 08520-1401
Is this the product you have?
Pioglitazone Tablets USP45 mg500 count bottles
- Distributed byAurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
- Lot codes and dates
Batch # PF4520028B & PF4520028AExp. Date 11/2022
- Amount recalled
- 792 bottles
Where it was sold
- Nationwide
Why it was recalled
Superpotent and Failed Tablet/Capsule Specifications
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aurobindo Pharma USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.